London, 11th November 2019: NMC Health plc (LSE:NMC) ('NMC'), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, received notification from Jonathan Bomford, the Senior Independent Director of the Company, that on 11th November he sold 1,000 ordinary shares of 10p each in the Company ("Shares") at a price of 2271.146 pence per share, and subsequently purchased through his SIPP 1,000 ordinary shares of 10p each in the Company ("Shares") at a price of 2257.950 pence per share.
Following this transaction, Jonathan Bomford's share interest, including the shares held by his spouse, remains at 20,000 Shares, representing approximately 0.01% of the issued share capital of the Company.
The Notification of Dealing Form for Jonathan Bomford can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Details of the person discharging managerial responsibilities / person closely associated
Senior Independent Non-Executive Director
Initial notification /Amendment
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Nature of the transaction
Share sale and re-purchase through SIPP
SALE Price(s) and volume(s)
PURCHASE Price(s) and volume(s)
No. of shares
No. of shares
2271.146 pence 2257.950 pence
£ 22,711.46£ 22,579.50
Date of the transaction
11 November 2019
Place of the transaction
London Stock Exchange
Simon Watkins, Group Company Secretary
+44 (0)20 3205 7313
FTI Consulting, London
+44 (0)20 3727 1000
FTI Consulting, Gulf
+971 (0)4 437 2100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...